Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × lutetium Lu 177 dotatate × NET × Clear all

Phase

Phase 2 18 Phase 1 6 Phase 3 5 Phase 1/2 3 Phase NA 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2 NET 1

Conditions

Neuroendocrine Tumors 1

Interventions

Everolimus 2 Al18F-NOTA-octreotide 2 lutetium Lu 177 dotatate 1 Somatostatin 1 Sirolimus 1 Positron Emission Tomography Computed Tomography 1 Oxaliplatin 1 Leucovorin 1 Injections 1 Fluorouracil 1 Bevacizumab 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03590119 2022-11-08

LUTIA

UMC Utrecht

Phase 2/3 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡